Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,767 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04142047Recruiting
Study muscle energy and fatigue in older adults
This study measures how older adults’ muscles use energy and how easily they tire during activity. It includes both people with HIV (with stable treatment and an undetectable viral load) and people without HIV to better understand differences in fatigue.
Baltimore, MarylandAges 60–90 - NCT04166266Recruiting
Study of adults with hepatitis D and hepatitis B coinfection
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
AngersAges 18 years+ - NCT04169542Recruiting
Study on how COVID-19 affected costs for breast surgery patients
This study asks people with breast cancer who are having breast surgery about how COVID-19 affected their out-of-pocket costs, work income, and job stability. Your answers may help improve support for patients during public health emergencies.
Conroe, TexasAges 18 years+ - NCT04174755Recruiting
Semaglutide for weight loss in adults with HIV
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
Dublin, DublinAges 18 years+ - NCT04191551Recruiting
Study of stomach precancer conditions during endoscopy
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
Stanford, CaliforniaAges 35–84 - NCT04226313Recruiting
Home self-swab tests for people not doing cervical screening
This study looks at whether a home self-sampling swab can help people who haven’t joined cervical cancer screening in the past few years. If you qualify, you’ll be asked to collect a swab yourself so it can be tested, aiming to make screening easier to access.
OlomoucAges 30–65 - NCT04263792RecruitingPhase 1
Scan trial to track a new tracer in suspected bacterial infections
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04271397Recruiting
Testing immune blood markers in tuberculosis care
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
LyonAges 18 years+ - NCT04291768RecruitingPhase 4
Shorter 5-day antibiotics for certain gram-negative bloodstream infections
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
AalborgAges 18 years+ - NCT04294043RecruitingPhase 1
Gallium IV study for adults with cystic fibrosis and NTM lung infection
This Phase 1 study tests whether an IV medicine called gallium can treat hard-to-treat lung infections (NTM) in adults with cystic fibrosis. It is mainly for people who have not been treated yet for NTM or who have NTM that has not cleared despite antibiotics.
Birmingham, AlabamaAges 18 years+ - NCT04318366Recruiting
Study of COVID-19 samples and how patients respond to treatment
This trial collects and studies COVID-19 test results and other patient information to better predict treatment response and outcomes. Your sample(s) help researchers understand who may improve, worsen, or need different care.
Milan, LombardyAges 18 years+ - NCT04319367RecruitingPhase 2
Antibody treatment added to HIV meds for early HIV
This Phase 2 trial tests whether adding long-acting HIV antibodies to standard HIV treatment (ART) can help control HIV in people who started ART soon after getting infected. It also checks how safe the antibody treatment is and how well it works over time.
AarhusAges 18–60 - NCT04320732Recruiting
Study COVID-19 spread at home and work
This study looks at what factors make COVID-19 spread more easily in the community and workplace. It may help researchers understand how to reduce transmission in everyday settings.
OsloAges 18 years+ - NCT04323904Recruiting
Hantavirus registry for people with kidney or lung symptoms
This study is a registry, meaning it collects health information and possibly test results from people who have evidence of hantavirus infection along with specific illness symptoms. It may help researchers better understand how hantavirus affects the kidneys or the heart/lungs (and how to recognize it).
Cologne, North-Rhine WestfaliaAges Any age - NCT04327570Recruiting
Study of immune responses in hospitalized COVID-19 patients
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
LeuvenAges 18 years+ - NCT04330287Recruiting
Study of heart health in adults aging with HIV
This study looks at how aging affects heart health in people who have HIV. It may help researchers find better ways to prevent or monitor heart problems over time.
Essen, NordrheinwestfalenAges 18 years+ - NCT04362150Recruiting
Study of long-term effects after COVID-19 infection
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
San Francisco, CaliforniaAges 18–100 - NCT04367857Recruiting
Study of COVID antibody levels in healthcare workers
This study measures how many healthcare workers have COVID antibodies (proof of past infection or immune response). Results may help estimate how widespread COVID exposure has been among hospital staff.
New York, New YorkAges 18 years+ - NCT04367883Recruiting
Study of flu shots and blood-pressure medicines in COVID
This study looks at people who were admitted to the hospital in Terrassa starting in March 2020. Researchers want to see whether having a flu vaccine and using certain blood-pressure medicines (ACE inhibitors or ARBs) is linked to how COVID infection develops.
Terrassa, BarcelonaAges Any age - NCT04380038RecruitingPhase 4
Viral infection study in well-controlled asthma adults
This study looks at how a viral infection affects people with well-controlled asthma. It tests whether specific asthma-related immune signals can predict who reacts more to a virus, which may help guide future asthma care.
Charlottesville, VirginiaAges 18–40 - NCT04382846RecruitingPhase 3
Testing new treatment combinations for COVID-19
This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.
TantaAges 18 years+ - NCT04439916Recruiting
Preventing CMV after lung transplant in special donor/recipient pairs
This study looks at how to prevent and monitor a virus called CMV after a lung transplant. It is for adults who are not carrying CMV themselves, but who receive lungs from donors who are CMV-positive, and it may help tailor safer follow-up care after transplant.
Edmonton, AlbertaAges 18 years+ - NCT04442789Recruiting
Study of lasting effects after COVID-19 hospitalization
This study looks at what health problems remain after a person was hospitalized for COVID-19. It may help doctors understand these long-lasting effects and how to care for people afterward.
GiessenAges 18 years+ - NCT04446676Recruiting
Stabilization method after staged knee revision for infection risk
This study compares two ways of stabilizing a knee implant after a two-step (staged) knee revision to see which better prevents reinfection. It may help people trying to avoid another infection after treatment of a previously infected knee implant.
Otwock, Masovian VoivodeshipAges 18–90
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,767 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.